Sirtex Medical Ltd. | Ownership
Companies that own Sirtex Medical Ltd.
Sand Grove Capital Management LLP
3,198,432
5.73%
3,198,432
5.54%
08/30/2018
MLC Investments Ltd.
3,020,283
5.41%
237,208
1.53%
08/03/2018
Perpetual Investment Management Ltd.
2,879,052
5.16%
-1,213,451
0.53%
01/09/2017
Pengana Capital Ltd.
2,838,081
5.09%
-314,803
11.22%
04/20/2017
Yarra Funds Management Ltd.
2,790,915
5%
-854,032
4.51%
10/13/2017
Norges Bank Investment Management
2,783,075
4.99%
-118,922
0.01%
05/01/2018
Allan Gray Australia Pty Ltd.
2,776,364
4.98%
-728,236
2.13%
05/25/2018
Consonance Capital Management LP
2,667,680
4.78%
-1,978,080
3.3%
01/31/2018
Macquarie Bank Ltd.
2,343,159
4.2%
-775,727
3.6%
09/03/2018
BlackRock Investment Management (Australia) Ltd.
1,380,193
2.47%
0
0.15%
04/27/2018
| Address |
101 Miller Street
North Sydney New South Wales (NSW) 2060
Australia
|
|
Employees
|
- |
| Website |
http://www.sirtex.com |
| Updated |
09/14/2018 |
| Sirtex Medical Ltd. engages in the research, commercial development, manufacture, and distribution of liver cancer treatments. It offers targeted radiation therapy known as SIR-Spheres Y-90 resin microspheres. Its clinical programs include SIRFLOX, FOXFIRE/FOXFIRE Global, SARAH, SIRveNIB, and SORAMIC. |
